User profiles for "author:Victoria Gamerman"

Victoria Gamerman

Boehringer Ingelheim
Verified email at boehringer-ingelheim.com
Cited by 505

Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second …

CS Chu, J Boyer, DS Schullery, PA Gimotty… - Cancer Immunology …, 2012 - Springer
Purpose In spite of increased rates of complete response to initial chemotherapy, most
patients with advanced ovarian cancer relapse and succumb to progressive disease …

[HTML][HTML] Pragmatic randomized clinical trials: best practices and statistical guidance

V Gamerman, T Cai, A Elsäßer - Health Services and Outcomes Research …, 2019 - Springer
Randomized clinical trials often serve the purpose of assessing the efficacy and safety of a
compound. By combining real-world evidence and randomization, pragmatic randomized …

Physician–patient communication at diagnosis of type 2 diabetes and its links to patient outcomes: New results from the global IntroDia® study

WH Polonsky, M Capehorn, A Belton, S Down… - Diabetes research and …, 2017 - Elsevier
Aims To investigate patient experiences during the diagnosis of type 2 diabetes mellitus
(T2DM), focusing on how physician–patient communication at diagnosis influences patients' …

[HTML][HTML] The influence of gender, race, and marital status on survival in lung cancer patients: analysis of Radiation Therapy Oncology Group trials

F Siddiqui, K Bae, CJ Langer, JC Coyne… - Journal of thoracic …, 2010 - Elsevier
Objective A meta-analysis was conducted to determine the influence of gender, race, and
marital status on overall survival (OS) in Radiation Therapy Oncology Group nonoperative …

Rationale for and design of the Idiopathic Pulmonary Fibrosis–PRospective Outcomes (IPF-PRO) registry

EC O'Brien, MT Durheim… - BMJ open …, 2016 - bmjopenrespres.bmj.com
Background Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease
characterised by progressive loss of lung function. Its clinical course is variable but …

Late consequential surgical bed soft tissue necrosis in advanced oropharyngeal squamous cell carcinomas treated with transoral robotic surgery and postoperative …

JN Lukens, A Lin, V Gamerman, N Mitra… - International Journal of …, 2014 - Elsevier
Purpose A subset of patients with oropharyngeal squamous cell carcinoma (OP-SCC)
managed with transoral robotic surgery (TORS) and postoperative radiation therapy (PORT) …

Physician–patient communication at prescription of an additional oral drug for type 2 diabetes and its links to patient outcomes–New findings from the global IntroDia® …

S Edelman, A Belton, S Down, M Capehorn… - Diabetes research and …, 2019 - Elsevier
Aims To investigate experiences of people with type 2 diabetes (T2DM) at the clinic visit
when an additional oral antidiabetes drug (OAD) is prescribed, and how this affects their …

The immunomodulatory effects of pegylated liposomal doxorubicin are amplified in BRCA1− deficient ovarian tumors and can be exploited to improve treatment …

G Mantia-Smaldone, L Ronner, A Blair… - Gynecologic …, 2014 - Elsevier
Objective Women with BRCA-associated ovarian cancer demonstrate excellent responses
to Pegylated Liposomal Doxorubicin (PLD). PLD has also been shown to enhance T cell …

[BOOK][B] Statistical methods for time-conditional survival probability and equally spaced count data

VA Gamerman - 2016 - search.proquest.com
This dissertation develops statistical methods for time-conditional survival probability and for
equally spaced count data. Time-conditional survival probabilities are an alternative …

Physician experiences when discussing the need for additional oral medication with type 2 diabetes patients: Insights from the cross-national IntroDia® study

S Down, WH Polonsky, A Belton, S Edelman… - Diabetes Research and …, 2019 - Elsevier
Aims Physician-patient communication when discussing the need for additional oral
medication for type 2 diabetes (add-on) may affect the self-care of people with this condition …